|
Volumn 6, Issue 1, 2011, Pages 19-22
|
Emerging resistance in Gram-negative pathogens and implications for clinical practice
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
CARBAPENEM;
CEFOXITIN;
CEPHALOSPORIN;
CIPROFLOXACIN;
ERTAPENEM;
IMIPENEM;
PIPERACILLIN PLUS TAZOBACTAM;
ACINETOBACTER BAUMANNII;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ANTIMICROBIAL ACTIVITY;
BACTERIUM ISOLATE;
COMMUNICABLE DISEASE;
CONFERENCE PAPER;
ENTEROBACTER CLOACAE;
ESCHERICHIA COLI;
GRAM NEGATIVE BACTERIUM;
HOSPITAL INFECTION;
KLEBSIELLA PNEUMONIAE;
MINIMUM INHIBITORY CONCENTRATION;
MULTIDRUG RESISTANCE;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
ANTI-BACTERIAL AGENTS;
BACTERIAL PROTEINS;
BETA-LACTAMASES;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
DRUGS, INVESTIGATIONAL;
GRAM-NEGATIVE BACTERIA;
GRAM-NEGATIVE BACTERIAL INFECTIONS;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
NEGIBACTERIA;
|
EID: 78650470902
PISSN: 17460913
EISSN: None
Source Type: Journal
DOI: 10.2217/fmb.10.150 Document Type: Conference Paper |
Times cited : (7)
|
References (2)
|